63 companies

Incyte

Market Cap: US$24.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$120.52

7D

1.8%

1Y

39.9%

Orion Oyj

Market Cap: €11.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€77.40

7D

-5.0%

1Y

14.2%

Exelixis

Market Cap: US$12.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$50.61

7D

-3.0%

1Y

31.6%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥54.2b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

688578

CN¥120.40

7D

2.9%

1Y

31.6%

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥43.4b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

688336

CN¥48.40

7D

3.1%

1Y

35.1%

Abbott India

Market Cap: ₹575.4b

Operates as a pharmaceutical company in India.

500488

₹27,076.90

7D

-2.5%

1Y

-18.5%

3SBio

Market Cap: HK$43.7b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

1530

HK$17.53

7D

-2.4%

1Y

-47.7%

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

ACAD

US$28.38

7D

-0.2%

1Y

15.7%

SK Biopharmaceuticals

Market Cap: ₩6.8t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩87,300.00

7D

2.2%

1Y

-13.2%

Ajanta Pharma

Market Cap: ₹458.7b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

AJANTPHARM

₹3,672.80

7D

5.3%

1Y

36.7%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹455.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹2,689.10

7D

3.7%

1Y

-2.9%

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥31.9b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥120.40

7D

-1.1%

1Y

6.4%

Sumitomo Pharma

Market Cap: JP¥615.5b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,372.00

7D

5.9%

1Y

-0.6%

Xiamen Amoytop Biotech

Market Cap: CN¥24.8b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥60.80

7D

8.6%

1Y

-29.0%

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥24.2b

Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

600329

CN¥36.17

7D

-2.7%

1Y

-18.4%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€57.95

7D

-0.7%

1Y

2.7%

Neuland Laboratories

Market Cap: ₹299.1b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

524558

₹23,311.50

7D

2.0%

1Y

75.8%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.9b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

4015

ر.س142.00

7D

1.4%

1Y

-12.7%

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

CDNA

US$47.38

7D

5.7%

1Y

300.8%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥14.8b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

300573

CN¥41.40

7D

-2.8%

1Y

-4.9%

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$9.41

7D

-6.5%

1Y

-44.5%

HBM Holdings

Market Cap: HK$13.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$15.10

7D

6.4%

1Y

23.9%

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

INVA

US$20.75

7D

-1.7%

1Y

-0.6%

CORONA Remedies

Market Cap: ₹130.7b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

CORONA

₹2,137.10

7D

3.8%

1Y

n/a

ChemoMetec

Market Cap: DKK 8.3b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 466.00

7D

8.4%

1Y

-7.0%

BioGaia

Market Cap: SEK 11.4b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 113.00

7D

1.3%

1Y

19.6%

Oscotec

Market Cap: ₩1.4t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

A039200

₩37,400.00

7D

7.0%

1Y

8.4%

Soho Global Health

Market Cap: Rp14.9t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

SOHO

Rp1,175.00

7D

-2.1%

1Y

66.7%

Zevra Therapeutics

Market Cap: US$679.4m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$11.18

7D

-5.9%

1Y

25.6%

CorMedix

Market Cap: US$557.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$8.14

7D

8.4%

1Y

-35.4%

Rafa Laboratories

Market Cap: ₪1.4b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

RAFA

₪14.69

7D

-7.7%

1Y

n/a

Onconic Therapeutics

Market Cap: ₩672.5b

Engages in the research and development of anti-cancer therapy in South Korea.

A476060

₩14,810.00

7D

5.4%

1Y

139.4%

DHG Pharmaceutical

Market Cap: ₫12.2t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

DHG

₫93,600.00

7D

-2.1%

1Y

-8.4%

Q32 Bio

Market Cap: US$457.6m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

QTTB

US$15.37

7D

-5.1%

1Y

717.6%

Abeona Therapeutics

Market Cap: US$425.2m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

ABEO

US$6.35

7D

-8.0%

1Y

-12.2%

GlaxoSmithKline Pakistan

Market Cap: PK₨109.8b

A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.

GLAXO

PK₨344.70

7D

-1.2%

1Y

-18.3%

Page 1 of 2